How will we ever hope to make desperately needed progress in the breast cancer crisis when the mainstream breast cancer motion continues to push an outdated and scientifically debunked agenda? The evidence has been mounting that the time has come to radically re-think the tenets of the breast cancer awareness motion, simply because it is clear that the fundamental philosophy behind “early detection” is flawed.
As the executive director of a national breast cancer organization, I would hope that our country’s major cancer organizations would be the very first to adhere to the science and place people’s wellness ahead of vested sector interests. But as head of the national watchdog for the breast cancer motion, I see that even potent evidence cannot overcome the vested interests of many of the greatest cancer organizations in the nation – nonprofits like the American Cancer Society (ACS) and the Susan G Komen Basis – which carry on to push screening mammograms with out caution.
This month, the New England Journal of Medicine published a strongly-worded viewpoint from the Swiss Health-related Board concluding that mammography screening is “tough to justify”. It followed the February publication of the biggest review on mammography to date in the British Medical Journal, which reported that screening healthful ladies with mammography to find breast cancers – just before they could be felt as a lump in the breast – did not lead to lower death charges for common-threat girls in their 40s and 50s.
In calculating the position of population-based screening, the absence of advantage is only compounded by evidence of harm: 21.9% of breast cancers located through mammography screening represented in excess of-diagnosis, in accordance to the Swiss Health care Board. This signifies that a single in five girls who was informed she had breast cancer following mammography screening received pointless treatment. The implication of these benefits is that tens of 1000′s of girls in the US every single yr undergo surgical treatment, radiation and chemotherapy for non-daily life threatening cancers.
Why, then, do mainstream cancer organizations, like ACS and Komen, carry on to guarantee that “early detection saves lives”? Their mantra has not altered despite the escalating certainty that this kind of claims are inflated and imbalanced.
The standpoint published by the New England Journal of Medication (NEJM) stems from an independent multidisciplinary panel’s review of the data close to mammography screening and concludes that “providing clear, unbiased info, marketing suitable care, and avoiding more than-diagnosis and above-therapy would be a greater decision [than advertising mammography screening plans].”
But the mainstream breast cancer motion, which is financed largely by pink ribbons and mostly focuses on early detection applications, has not responded with proof-based mostly modifications to their positions and educational resources. The websites for ACS and for Komen carry on to eagerly push screening mammograms for women age forty and above with no acknowledgment of the harms of screening applications. Indeed, the American Cancer Society delivers to send females a “free breast cancer screening reminder” – and grow their very own (monetizable) email listing.
Soon after many years of pink-ribbon “awareness” campaigns, the NEJM study factors out, several women in the US overestimate their private danger of breast cancer. In addition, they vastly overestimate the advantage from mammograms. Females feel their risk of dying from breast cancer is double if they do not undergo typical mammography screening. However the information present that there is no proof that schedule mammography screening for women at typical danger saves lives.
At what level are we going to cease this madness, consider stock of the science and acknowledge that widespread screening mammography for non-substantial danger females is not the reply to the breast cancer epidemic?
When are we going to hold our cancer charities to a larger common – and hold them accountable for pushing a scientifically invalid message?
And are we ever going to query what we truly have to demonstrate for the billions of bucks invested on screening mammograms?
In spite of leading the world in well being spending, the US notably lags in several well being outcomes. As research and analyses on mammography screening continue to cast doubt on this strategy, there is a expanding trend in Europe to phase out population-based mostly mammography screening for wholesome women at average threat of breast cancer. However here in the US, mammography screening remains a basis of the mainstream breast cancer motion, which has informed us for more than 30 many years that early detection is the answer to the breast cancer epidemic.
The proof is in. We will never ever tackle and end the breast cancer epidemic simply by way of mammography screening. The issue is not basically the tool but the standard philosophy of early detection.
Our healthcare alternatives are driven by the expectation that they will enhance and lengthen our lives – yet mammography screening does neither. As an alternative, widespread population-primarily based screening has produced a population of over-diagnosed breast cancer “survivors” with no really saving the lives of many of those same females.
As each and every female evaluates her overall health selections, we have to make sure that we all have entry to unbiased data, cost-free from conflict of curiosity and with out the heavy thumb of vested interests tipping the stability.
Breast cancer mammograms: overrated, overhyped and in excess of-diagnosing females | Karuna Jaggar
Hiç yorum yok:
Yorum Gönder